Opportunity Information: Apply for 72065623APS00001
The USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity is a health-focused funding opportunity issued by USAID in Mozambique through the USAID-Maputo mission. The opportunity is identified by the title "USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity" and the funding opportunity number 72065623APS00001. It falls under an "Other" opportunity category and uses an "Other" funding instrument type, which typically signals that the detailed application requirements, selection approach, and award structure are explained in the full notice and its attachments rather than being easily inferred from a standard grant template.
Based on the title and program framing, the activity is intended to improve outcomes across the continuum of care for mothers, newborns, and children, while also strengthening immunization performance and nutrition interventions. In practical terms, opportunities like this usually aim to reduce preventable maternal and child illness and deaths by improving the quality, coverage, and equity of essential health services. That can include strengthening antenatal, delivery, and postnatal care; improving essential newborn care and management of childhood illnesses; increasing routine immunization uptake and system performance; and reducing malnutrition through prevention, early identification, and appropriate treatment or referral. The program title suggests an integrated approach, meaning maternal health, newborn care, child health, immunization, and nutrition are treated as interlinked service areas rather than separate vertical programs.
The awarding agency is USAID-Maputo, and the CFDA (now commonly referred to under assistance listings) number is 98.001, which is a broad USAID foreign assistance listing. The eligible applicant field is listed as "Unrestricted," indicating that the competition is open to a wide range of entities rather than being limited to a specific applicant class. In many USAID opportunities, "unrestricted" can include non-profit organizations, for-profit organizations, universities, research institutions, and potentially local entities, subject to the specific eligibility rules and compliance requirements described in the full solicitation.
Financially, the opportunity lists an award ceiling of 92,000,000, indicating the maximum funding amount anticipated for an award under this opportunity. The number of expected awards is not provided in the source data, so it is not clear from the summary whether USAID planned to make a single large award or multiple awards. The notice was created on 2023-08-16, and the original closing date is 2023-10-31. Those dates suggest a relatively standard application window for a major USAID health activity, but any amendments, Q&A deadlines, concept note phases, or revised closing dates would normally be contained in the attachments or subsequent updates.
The posted description in the source data states "See attachment. N/A.," which means the core technical description, scope of work, geographic focus within Mozambique, expected results, monitoring and evaluation requirements, and application instructions were not included in the text provided here. In a typical USAID health activity of this scale, the attachment would usually spell out the program objectives, expected deliverables, implementation period, key indicators, coordination expectations with the Ministry of Health and other partners, requirements for safeguarding and compliance (for example, child safeguarding, protection from sexual exploitation and abuse, and data privacy), and the criteria USAID will use to evaluate applications. Without the attachment text, a precise scope summary, required partnership arrangements, and exact evaluation factors cannot be confirmed from the information provided.
In short, this opportunity is a large-scale USAID-Mozambique health activity focused on strengthening maternal and child health, newborn care, immunization systems, and nutrition interventions, with broad eligibility and a maximum award size of up to $92 million, originally closing on October 31, 2023. The specific technical priorities and application requirements are contained in the attachment referenced by the notice, which would be necessary to produce a fully accurate, line-by-line summary of what USAID is seeking and how proposals would be assessed.Apply for 72065623APS00001
- The Mozambique USAID-Maputo in the health sector is offering a public funding opportunity titled "USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2023-08-16.
- Applicants must submit their applications by 2023-10-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $92,000,000.00 in funding.
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity (Mozambique)
What is the name of this funding opportunity?
The opportunity is titled "USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity."
What is the funding opportunity number?
The funding opportunity number is 72065623APS00001.
Who is the awarding agency?
The awarding agency is USAID, through the USAID-Maputo mission in Mozambique (USAID-Maputo).
Where is this activity expected to take place?
Based on the issuing mission (USAID-Maputo), this activity is associated with Mozambique. The specific geographic focus within Mozambique is not included in the information provided and would normally be defined in the attachment(s) referenced by the notice.
What is the Assistance Listing (CFDA) number for this opportunity?
The listing number provided is 98.001, which is a broad USAID foreign assistance listing.
What is the opportunity category and funding instrument type?
The opportunity category is listed as "Other" and the funding instrument type is also listed as "Other." This usually indicates that the detailed application requirements, selection approach, and award structure are explained in the full notice and its attachment(s), rather than following a standard grant template.
What is the overall purpose of the activity?
Based on the title and framing, the activity is intended to improve outcomes across the continuum of care for mothers, newborns, and children, while also strengthening immunization performance and nutrition interventions. The information provided suggests an integrated approach across these service areas rather than separate, vertical programs.
What technical areas does the title suggest are included?
The title indicates a focus on: maternal health, newborn health, child health, immunization, and nutrition. The information provided also suggests these areas are meant to be addressed in an integrated way.
What kinds of results might an activity like this typically aim to achieve?
Opportunities described like this commonly aim to reduce preventable maternal and child illness and deaths by improving the quality, coverage, and equity of essential health services. The specific results and targets for this opportunity are not included in the provided text and would normally be detailed in the attachment(s).
What types of interventions are implied by the description provided?
Based on the summary provided (not the attachment), the activity could involve strengthening antenatal, delivery, and postnatal care; improving essential newborn care and management of childhood illnesses; increasing routine immunization uptake and system performance; and reducing malnutrition through prevention, early identification, and appropriate treatment or referral. The exact required interventions cannot be confirmed without the attachment.
Is this opportunity open to all applicants?
The eligible applicant field is listed as "Unrestricted," which indicates the competition is open to a wide range of entities rather than being limited to a specific applicant class. The exact eligibility rules and compliance requirements would be defined in the full solicitation and its attachments.
What kinds of organizations might be able to apply under an "Unrestricted" eligibility listing?
In many USAID opportunities, "unrestricted" can include non-profit organizations, for-profit organizations, universities, research institutions, and potentially local entities, subject to the specific rules in the full solicitation.
How much funding is available?
The opportunity lists an award ceiling of 92,000,000, meaning the maximum funding amount anticipated for an award under this opportunity is up to $92 million.
Does the award ceiling mean every applicant can receive $92 million?
No. The award ceiling is the maximum anticipated amount for an award under the opportunity. The information provided does not state how USAID plans to structure the award(s) or what typical award sizes might be.
How many awards does USAID expect to make?
The number of expected awards is not provided in the information given. It is not possible to confirm from this summary whether USAID anticipated one award or multiple awards.
When was this opportunity created/posted?
The notice was created on 2023-08-16.
What was the original closing date?
The original closing date listed is 2023-10-31.
Could the closing date change or have been amended?
Yes. The provided information notes an original closing date, but any amendments, revised deadlines, Q&A timelines, or phased submission requirements would typically appear in the attachments or subsequent updates rather than in the short summary provided here.
Where is the detailed scope of work and application instructions?
The posted description states "See attachment. N/A.," which indicates that the main technical description, scope, geographic focus, expected results, monitoring and evaluation expectations, and application instructions are contained in the attachment(s) referenced by the notice, not in the text provided here.
What information is missing from the provided summary that applicants would normally need?
The information provided does not include the detailed technical scope, specific geographic coverage within Mozambique, expected results framework, required deliverables, implementation period, monitoring and evaluation requirements, application format and submission instructions, or the evaluation criteria USAID will use. These items are typically spelled out in the attachment(s).
What evaluation criteria will USAID use to review applications?
The evaluation criteria are not included in the provided text. They would normally be included in the attachment(s) associated with the full notice.
What is meant by an "integrated approach" in this opportunity?
Based on the description provided, an integrated approach means maternal health, newborn care, child health, immunization, and nutrition are treated as interlinked service areas rather than separate program tracks. The exact integration expectations for implementation would be described in the attachment(s).
Does the summary specify the activity duration or period of performance?
No. The implementation period is not provided in the text shared. This would typically be stated in the full notice or its attachment(s).
Does the summary specify required partnerships or coordination arrangements?
No. The information provided suggests that coordination expectations (for example, with the Ministry of Health and other partners) would typically be covered in the attachment(s), but those details are not included in the text provided here.
Are safeguarding and compliance requirements mentioned?
The summary notes that safeguarding and compliance requirements (for example, child safeguarding, protection from sexual exploitation and abuse, and data privacy) are often included in the attachment(s) for activities of this scale, but the actual requirements for this opportunity are not included in the provided text.
Does the notice text include a full program description?
No. The notice text provided contains minimal detail and explicitly points to an attachment for the full description.
What should an interested applicant do next based on the information provided?
The next step implied by the notice text is to review the attachment(s) referenced by the opportunity, since that is where the scope, requirements, deadlines, and evaluation criteria would normally be specified.
Browse more opportunities from the same category: Health
Next opportunity: Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
Previous opportunity: Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 72065623APS00001
Applicants also applied for:
Applicants who have applied for this opportunity (72065623APS00001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional) Apply for PAR 23 258 Funding Number: PAR 23 258 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) Apply for RFA AG 24 043 Funding Number: RFA AG 24 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed) Apply for RFA NS 24 027 Funding Number: RFA NS 24 027 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed) Apply for RFA NS 23 030 Funding Number: RFA NS 23 030 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18) Apply for PA 23 290 Funding Number: PA 23 290 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01) Apply for PA 23 291 Funding Number: PA 23 291 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) Apply for PAR 23 274 Funding Number: PAR 23 274 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 24 046 Funding Number: RFA AG 24 046 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 162 Funding Number: RFA MH 24 162 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA AG 24 027 Funding Number: RFA AG 24 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional) Apply for RFA RM 23 012 Funding Number: RFA RM 23 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Broadening Opportunities for Computational Genomics and Data Science Education (UE5 Clinical Trial Not Allowed) Apply for RFA HG 23 002 Funding Number: RFA HG 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional) Apply for RFA AG 24 031 Funding Number: RFA AG 24 031 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional) Apply for RFA AG 24 030 Funding Number: RFA AG 24 030 Agency: National Institutes of Health Category: Health Funding Amount: $2,750,000 |
| Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed) Apply for RFA DE 24 003 Funding Number: RFA DE 24 003 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed) Apply for PAR 22 268 Funding Number: PAR 22 268 Agency: National Institutes of Health Category: Health Funding Amount: $325,000 |
| Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 23 055 Funding Number: RFA AI 23 055 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Developing Salivary Components as Therapeutics for Oral Health (R01 Clinical Trial Not Allowed) Apply for RFA DE 24 004 Funding Number: RFA DE 24 004 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Developing Salivary Components as Therapeutics for Oral Health (R21 Clinical Trial Not Allowed) Apply for RFA DE 24 005 Funding Number: RFA DE 24 005 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed) Apply for RFA MH 25 145 Funding Number: RFA MH 25 145 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "72065623APS00001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.